SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-047721
Filing Date
2019-10-09
Accepted
2019-10-08 20:13:01
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS I, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv530718_sc13g.htm SC 13G 91443
2 EXHIBIT 99.1 tv530718_ex99-1.htm EX-99.1 6867
  Complete submission text file 0001144204-19-047721.txt   99893
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91159 | Film No.: 191143574
SIC: 2834 Pharmaceutical Preparations